Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Bariatric Surgery Rates Down by 26% in Recent Years: Report Amid increasing popularity of Ozempic, Wegovy and other GLP-1 drugs, researchers indicate that fewer patients are considering weight loss surgery. November 12, 2024 Martha Garcia Add Your Comments Over the past few decades, Americans who want to lose weight have often turned to bariatric surgery. However, a new study suggests that more people are now turning to prescription medications like Ozempic, Wegovy, Mounjaro and Zepbound to take the weight off. Bariatric surgeries include gastric sleeve procedures, like LapBand, and gastric bypass. Gastric sleeve procedures remove roughly 80% of the stomach, which reduces the size of the stomach and forces patients to eat much less. Another procedure, known as Roux-en-Y Gastric Bypass, involves the stomach being divided and rerouted to the lower portion of the small intestine, effectively closing off a part of the stomach. Doctors often recommend bariatric surgery to obese patients to help them lose large amounts of weight and improve conditions like diabetes and hypertension. These types of surgeries are used when traditional methods like diet and exercise no longer work, and patients are severely overweight. However, findings published last month in JAMA Network Open, show that in recent years obese patients who want to lose weight are turning to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic and Mounjaro, which started out as diabetes medications and are now being used more and more for weight loss. Ozempic (semaglutide) is a Novo Nordisk type 2 diabetes drug approved by the FDA in December 2017, as a once-weekly injection. However, the manufacturer has convinced the FDA to expand the drug’s approval over the years, including indications for the prevention of diabetes-related heart disease, and the approval of increasingly more powerful doses. Novo Nordisk has also introduced a separate version of the drug under the brand name Wegovy, which is approved and marketed for weight loss, but there have been growing concerns about side effects of Ozempic and Wegovy in recent years, including reports that users have been left with stomach paralysis and severe gastrointestinal problems, which lawsuits now allege was not adequately disclosed on the drug label. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Mounjaro (tirzepatide) is a similar GLP-1 receptor agonist that was introduced by Eli Lilly in May 2022, and approved for treating type 2 diabetes. Following the success of Novo Nordisk’s Wegovy product, Eil Lilly created its own weight loss version of Mounjaro, which is marketed as Zepbound. Over the past few years, sales for these new weight loss drugs has risen dramatically, and some estimates suggest that GLP-1 sales are expected to surpass $100 billion per year by 2029. Bariatric Surgery Demand Decreasing In this new study, researchers from Harvard and Brigham and Women’s Hospital in Boston analyzed national trends involving obese patients who were prescribed GLP-1s, and compared those with bariatric surgery. A team of researchers led by Dr. Thomas C. Tsai used anonymous medical records from 2022 to 2023, comparing nearly 82,000 patients using GLP-1 drugs with 5,200 patients who underwent bariatric surgery. According to the findings, use of GLP-1 drugs like Ozempic and Wegovy doubled during that time period. In addition, the data also showed a 26% decrease in the number of patients who had bariatric surgery. The researchers noted that use of drugs like Ozempic and Zepbound jumped 133% between the last six months of 2022, and the last six months of 2023. They determined that, during that time period, more patients began opting for weight loss drugs. Researchers also said the GLP-1 drugs were an effective treatment for obesity and diabetes, but were more costly and resulted in high rates of gastrointestinal side effects. As a result of these complications, researchers indicated many patients are quitting the drugs, and looking for other ways to lose weight. Study authors said more research is needed to assess the trends in bariatric surgery use compared to weight loss drugs. They also noted that doctors should closely monitor the trade-offs between the use of weight loss drugs and bariatric surgery to ensure patients are given the most effective obesity treatment in the long run and weigh all the risks and benefits. For example, a study published in 2019 by French researchers found bariatric surgeries increase the risk of a person suffering gastrointestinal complications. They faced a higher risk of hospital admission, needing invasive gastrointestinal surgery later, and suffering nutritional disorders. A study published the same year by Swedish researchers indicated many patients who have bariatric surgery often need revision surgery to correct problems, reverse the surgery completely, or convert the surgery to other types of bariatric surgery. GLP-1 Side Effects Concerns Dr. Tsai’s findings come as more and more concerns are raised over the potential side effects of drugs like Ozempic and Mounjaro, indicating that while the drugs are effective at treating diabetes and helping promote weight loss, they appear to lack adequate warnings about the risks of severe gastrointestinal problems, such as intestinal obstructions and gastroparesis. Gastroparesis, also known as delayed gastric emptying or stomach paralysis, weakens the normal muscle movement in the stomach. These stomach contractions are necessary to push food through the digestive tract. When gastroparesis occurs, the stomach is slow to empty, resulting in symptoms like nausea, vomiting undigested food, abdominal pain, abdominal bloating, severe dehydration, feeling full after only a few bites, undigested food hardening in the stomach, acid reflux, fluctuating blood sugar levels, lack of appetite, weight loss, malnutrition and decreased quality of life. As a result of the drug makers’ failure to disclose these side effects to users and the medical community, there are currently hundreds of Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits being filed in federal courts nationwide. Given common questions of fact and law raised in the claims, all federal GLP-1 lawsuits have been centralized as part of an MDL, or multidistrict litigation, where U.S. District Judge Karen S. Marston is overseeing coordinated discovery and pretrial proceedings. Tags: Bariatric Surgery, Gastric Bypass, Gastric Sleeve, Gastroparesis, Lap-Band, Mounjaro, Ozempic, Stomach Paralysis, Wegovy, Weight Loss Surgery, Zepbound Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories NAION Ozempic Lawsuit Filed After User’s Eye Suffers 85% Vision Loss July 10, 2025 Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study June 23, 2025 Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court June 18, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: today) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025) Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: yesterday) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025) Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 2 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: today) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: yesterday) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025)
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 2 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)